You can buy or sell BIO and other stocks, options, ETFs, and crypto commission-free!
Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through Life Sciences and Clinical Diagnostics segments. Read More The Life Science segment develops, manufactures and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells and supports test systems, informatics systems, test kits and specialize in quality controls that serve clinical laboratories in the global diagnostics market. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.
52 Week High
52 Week Low
Recent Trend: Bio-Rad Laboratories (NYSE: BIO)
Bio-Rad Laboratories trades as part of the healthcare sector and is in the medical diagnostics and research industry. Bio-Rad Laboratories Inc manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a products and systems used to separate complex chemical and biological materials. Previous Intraday Trading Performance: The BIO stock showed a previous change of 1.08% with an open at 310.17 and a close of 313.67. It reached an intraday high of 313.80 and ...
Yahoo FinanceMar 15
Looking for a Growth Stock? Why It is Time to Focus on Bio-Rad (BIO)
Growth stocks can be some of the most exciting picks in the market, as these high-flyers can captivate investors’ attention, and produce big gains as well.
Yahoo FinanceMar 12
Here is Why Growth Investors Should Buy Bio-Rad (BIO) Now
Agnico (AEM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. However, it isn't easy to find a great growth stock. In addition to volatility, these stocks carry above-average risk by their very nature. Also, one could end up losing from a stock whose growth story is actually ove...
Expected May 7, After Hours